U.S. Mortgage Finance Stock News

NYSE:WEX
NYSE:WEXDiversified Financial

Is WEX (WEX) Cheap On Raised Guidance And A Second Quarter Earnings Beat?

WEX (WEX) shares were in focus after the company reported second quarter 2026 results that beat earnings and revenue estimates, raised full year guidance, and outlined plans to prioritize share repurchases. See our latest analysis for WEX. WEX shares trade at US$199.93, with a 1-month share price return of 13.5% and a 90-day share price return of 32.8%, while the 1-year total shareholder return sits at 15.6%, indicating recent positive momentum following earnings and guidance. If strong...
NYSE:PKG
NYSE:PKGPackaging

Is Packaging Corporation of America (PKG) Undervalued As Strong Earnings And Outlook Lift Interest?

Packaging Corporation of America (PKG) drew fresh investor attention after reporting second quarter 2026 adjusted earnings above consensus, supported by higher production, stronger sales volumes, and contributions from its recent Greif acquisition. See our latest analysis for Packaging Corporation of America. Packaging Corporation of America’s recent earnings beat and Greif integration come after a strong run, with a 19.74% year to date share price return and a 93.51% five year total...
NYSE:SMG
NYSE:SMGChemicals

What Scotts Miracle-Gro (SMG)'s Fiduciary Probe and Lawsuit After 2023 Results Mean For Shareholders

Kahn Swick & Foti, LLC recently continued its investigation into The Scotts Miracle-Gro Company over potential fiduciary breaches after 2023 results revealed a 6% sales decline, a 420 basis point gross margin reduction, a 25% cut to full-year EBITDA guidance, and a US$20,000,000 inventory write-down. These disclosures have already led to a securities class action lawsuit alleging failures to share material information, putting Scotts Miracle-Gro’s governance, disclosure practices, and risk...
NYSE:SXC
NYSE:SXCMetals and Mining

3 U.S. Manufacturing Stocks Tied To Tariff Driven Onshoring】【。

With a fresh US–Canada trade clash pushing tariffs higher and rattling cross border supply chains, investors face a new map of potential winners and losers. Sudden shifts in costs and sourcing can reshape where production happens and which companies keep pricing power. This article walks through three stocks from our U.S. Onshoring and Domestic Manufacturing Beneficiaries screener that appear well positioned for this moment. The stocks highlighted below are just a starting sample, and the...
NasdaqGM:OMER
NasdaqGM:OMERPharmaceuticals

Omeros (OMER) Turns Profitable As Fair Value Questions Come Into View

Omeros (OMER) is in focus after reporting a shift to net income in its second quarter and first half of 2026, replacing prior year losses and prompting fresh attention on the stock. See our latest analysis for Omeros. That shift to profit has coincided with sharp share price momentum for Omeros, with a 96.83% 1 month share price return and a 68.15% 3 month share price return. This has contributed to a very large 1 year total shareholder return. If strong recent gains in Omeros have you...
NYSE:ACN
NYSE:ACNIT

3 Dividend Stocks With 3%+ Yields Worth Watching Now

With 10 year US Treasury yields near recent highs as investors digest ongoing fiscal deficits and potential policy shifts, the search for dependable income feels more urgent. Cash rates may not stay where they are forever, yet inflation concerns still linger. That is where Dividend Powerhouses with 3%+ yields come in. This article highlights three stocks from the screener that offer income focused investors a starting shortlist. The three Dividend Powerhouses profiled below are just a small...
NasdaqGS:ILMN
NasdaqGS:ILMNLife Sciences

Why Illumina (ILMN) Stock Climbed And What Investors Are Watching Now

Why Illumina’s New Financing Matters For Stock Investors Illumina (ILMN) has just put in place a new US$1b senior unsecured revolving credit facility and completed a roughly US$300m fixed income offering. These financing steps give investors fresh information on the company’s balance sheet flexibility. The new credit agreement runs for five years, with options to extend to 2031. It replaces Illumina’s prior facility that was terminated on 13 August 2026. As of that date, the company reported...
NasdaqGS:CME
NasdaqGS:CMECapital Markets

What CME Group (CME)'s Push Into AI Compute and Niche Futures Means For Shareholders

CME Group has moved to broaden its derivatives line-up, introducing index-based Hockey futures, AI compute rental futures tied to GPU costs, and 24/7 trading for its 100‑Ounce Silver contract, alongside previously launched 1‑Ounce Gold weekend trading. Together, these launches extend CME’s reach into sports, AI infrastructure, and retail-friendly precious metals trading, highlighting how exchange-style risk management is being applied to increasingly unconventional underlying markets. We’ll...
NYSE:CACI
NYSE:CACIProfessional Services

Will New NY EW Hub and NITE-STAR Win Reshape CACI International's (CACI) Tech-Driven Federal Contract Narrative?

In August 2026, CACI International Inc. opened a 61,000-square-foot Manufacturing Center of Excellence for Defense Electronics near Rochester, New York, expanding its production footprint for advanced electronic warfare technologies and supporting the U.S. Army’s Terrestrial Layer System Brigade Combat Team Manpack program. Alongside this capacity build-out, CACI International Inc. was selected as one of 15 awardees on the US$981 million NITE-STAR IDIQ with the U.S. Space Force, underscoring...
NasdaqGS:HCSG
NasdaqGS:HCSGCommercial Services

Healthcare Services Group (HCSG), Why Is It Getting Fresh Attention Today?

Healthcare Services Group (HCSG) is back on investor radars after its Zacks Rank shifted to Strong Buy, alongside a 12.9% upward move in the full-year earnings consensus over the past quarter. See our latest analysis for Healthcare Services Group. At a share price of US$22.77, Healthcare Services Group has seen short term momentum cool slightly after a 1-day share price return that declined 1%, although a 90-day share price return of 11.45% and 1-year total shareholder return of 44.34% point...
NYSE:ESTC
NYSE:ESTCSoftware

Why Everyone Is Watching Elastic (ESTC) Today

Pictet Asset Management SA’s decision to engage with Elastic (NYSE:ESTC) on August 20, 2026, puts fresh attention on the company’s business practices and potential implications for long term shareholder value. See our latest analysis for Elastic. Elastic’s recent share price move to US$85.94 comes after a strong 30 day share price return of 46.46% and 90 day share price return of 56.80%. The 1 year total shareholder return of 7.34% and 3 year total shareholder return of 43.16% suggest...
OTCPK:DIDI.Y
OTCPK:DIDI.YTransportation

How Investors Are Reacting To DiDi Global (DIDI.Y) Returning To Quarterly Profit Amid First-Half Loss

DiDi Global Inc. has reported its second-quarter 2026 results, with sales rising to CNY 62,522 million and net income reaching CNY 866 million, marking a shift from a loss a year earlier. An interesting contrast emerges as the company delivered a profitable second quarter while still recording a net loss of CNY 354 million for the first half of 2026. We will now examine how DiDi Global’s return to quarterly profitability, alongside continued first-half losses, shapes the company’s investment...
NYSE:CNK
NYSE:CNKEntertainment

Cinemark Holdings (CNK) Could Be 5% Undervalued On Record Spider Man Box Office

Cinemark Holdings (CNK) is back in focus after announcing that Spider-Man: Brand New Day is now the highest grossing domestic film in its history, with record results in premium formats and related in-theater spending. See our latest analysis for Cinemark Holdings. Cinemark Holdings' latest record for Spider-Man: Brand New Day arrives during a strong run for the stock, with a 30-day share price return of 11.89% and a 90-day gain of 38.48%. The 1-year total shareholder return of 39.64% and...
NYSE:PFE
NYSE:PFEPharmaceuticals

Is Pfizer (PFE) Stock Too Pricey for Its Earnings Outlook?

Pfizer stock has returned 16.1% over the past year after a weaker five year stretch, while the valuation checks and market multiples now point to a mixed picture rather than a clear bargain. The share price is still down 21.5% over 5 years, which suggests longer term holders have not yet fully recovered their losses despite the recent rebound. Regulatory progress on the Lyme disease vaccine candidate and broader interest in mRNA and cancer antibody conjugate therapies can support sentiment,...
NYSE:EPC
NYSE:EPCPersonal Products

How Edgewell’s Revenue Miss and Margin Pressure Will Impact Edgewell Personal Care (EPC) Investors

Earlier this month, Edgewell Personal Care reported quarterly revenue up 1.7% year on year but below analysts’ expectations, with organic revenue and EBITDA missing estimates despite management highlighting a return to organic net sales growth and better-than-expected adjusted EPS and EBITDA. However, underlying trends such as weaker operating margins, downward EPS momentum, and an extended period of organic sales decline have raised fresh questions about the strength of Edgewell’s...
NasdaqGS:WYNN
NasdaqGS:WYNNHospitality

Labor Strains and Show Closure Could Be A Game Changer For Wynn Resorts (WYNN)

Wynn Resorts recently faced two operational setbacks: workers at Encore Boston Harbor authorized potential strike action after contract talks, and the costly "Awakening" show at Wynn Las Vegas was closed following sustained financial losses. Together, these developments highlight how labor relations and entertainment programming decisions can materially affect Wynn’s cost base, guest experience, and future cash allocation choices. We’ll now examine how the Boston labor tensions and costly...
NYSE:PII
NYSE:PIILeisure

Polaris (PII) Could Be 5% Undervalued As Tariff And Demand Risks Linger

Polaris (PII) is back in focus after shares closed at $64.39 on 19 August 2026, following weaker recent returns despite annual revenue and net income growth and a modest gap to fair value estimates. See our latest analysis for Polaris. Over the past year, Polaris has produced a 1-year total shareholder return of 17.62%, even as the share price return has softened recently with the 30-day share price return down 11.84% and the 3-year total shareholder return down 34.33%. If Polaris’s recent...
NYSE:CCS
NYSE:CCSConsumer Durables

Century Communities (CCS), Why Is The Market Paying Closer Attention Now?

Century Communities (CCS) is in focus after the grand opening of Uplands Phase II in Puyallup, Washington. The expansion adds new single family home designs and amenities in a well located master planned community. See our latest analysis for Century Communities. Against this backdrop, Century Communities’ share price sits at US$69.78, with a 90 day share price return of 34.32% and a 1 year total shareholder return of 5.51%, which points to momentum building more recently. If this kind of...
NYSE:SCCO
NYSE:SCCOMetals and Mining

Southern Copper (SCCO) Could Be 29% Overvalued On Record Q2 Results

Q2 results bring fresh focus to Southern Copper Southern Copper (SCCO) moved back into the spotlight after reporting record adjusted EBITDA of US$2.86b in Q2 2026, supported by higher metal prices, cost control, and a slightly higher full year copper production outlook. See our latest analysis for Southern Copper. The strong Q2 report arrived after a period of robust momentum for Southern Copper, with a 1-day share price return of 8.69% and a 30-day share price return of 21.92% at a US$216.0...
NasdaqGS:QCOM
NasdaqGS:QCOMSemiconductor

Will Qualcomm’s (QCOM) Hire of Motorola Veteran to Lead Personal AI Shift Its Core Narrative?

Earlier this year, Qualcomm announced the appointment of Sergio Buniac as executive vice president and group general manager of Mobile, Compute and Personal AI, placing him in charge of its smartphone, personal computing, smart wearables and XR businesses, including next-generation AI devices. Buniac’s move after more than three decades at Motorola brings broad product, operations and supply chain leadership that could shape how Qualcomm executes its ambitions in mobile and personal AI...
NYSE:CAAP
NYSE:CAAPInfrastructure

Corporación América Airports (CAAP) Reports Q2 2026 Results, Is The 28% Undervaluation Real?

Corporación América Airports (NYSE:CAAP) has just reported its second quarter 2026 results, providing fresh numbers on sales, earnings and traffic that can help frame what the stock currently reflects. See our latest analysis for Corporación América Airports. At a share price of US$23.46, Corporación América Airports has seen its 1 month share price return fall 6.8% and its year to date share price return fall 11.7%. However, the 1 year total shareholder return is 8.3% and the 5 year total...